SCHEMBL8031540

SCHEMBL8031540

CC(=O)/C=C1\Sc2ccc(O)cc2N1CCN1CCOCC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 10/20 0.65
CLK1 P49759 9/20 0.65
CSNK1E P49674 3/20 0.65
CLK3 P49761 3/20 0.65
DYRK1B Q9Y463 3/20 0.65
CLK2 P49760 2/20 0.65
CLK4 Q9HAZ1 2/20 0.65
DYRK3 O43781 1/20 0.65
GSK3B P49841 1/20 0.65
DYRK2 Q92630 1/20 0.65
DYRK4 Q9NR20 1/20 0.65
HTR2A P28223 2/20 0.48
HTR2C P28335 2/20 0.48
PIM1 P11309 2/20 0.47
CSNK1D P48730 2/20 0.47
CSNK1G2 P78368 2/20 0.47
MAP3K19 Q56UN5 2/20 0.47
PIM3 Q86V86 2/20 0.47
HSD17B10 Q99714 2/20 0.47
CSNK1G3 Q9Y6M4 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8035434 0.86 DYRK1A (0.51) DYRK1ACLK1CSNK1ECLK3DYRK1B
SCHEMBL8020262 0.86 DYRK1A (0.67) DYRK1ACLK1CSNK1ECLK3DYRK1B
SCHEMBL8029996 0.80 DYRK1A (0.46) DYRK1ACLK1CSNK1ECLK3DYRK1B
SCHEMBL30754671 0.80 CLK1 (1.00) DYRK1ACLK1CSNK1ECLK3DYRK1B
SCHEMBL5707661 0.80 CLK1 (1.00) DYRK1ACLK1CSNK1ECLK3DYRK1B
SCHEMBL29772696 0.80 CLK1 (1.00) DYRK1ACLK1CSNK1ECLK3DYRK1B
SCHEMBL5707659 0.80 CLK1 (1.00) DYRK1ACLK1CSNK1ECLK3DYRK1B
SCHEMBL4011674 0.80 CLK1 (1.00) DYRK1ACLK1CSNK1ECLK3DYRK1B
SCHEMBL8035429 0.77 DYRK1A (0.53) DYRK1ACLK1CSNK1ECLK3DYRK1B
SCHEMBL4017395 0.76 CLK1 (0.63) DYRK1ACLK1CSNK1ECLK3DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009085226-A2 INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF SIRTRIS PHARMACEUTICALS, INC. (US) 2009-07-09 WO disclosed